Inflammatory rhabdomyoblastic tumor: Clinicopathologic and genomic features, association with neurofibromatosis type 1, and progression to rhabdomyosarcoma

Tulio M. Silva, Marta Sesé, Miriam Magallón-Lorenz, Gustavo Tapia, Juan C. Tardío, Javier Hernandez-Losa, Bernat Gel, Nikaoly Ciriaco, Alejandro Alegría, Rosario Granados, Irma Ramos-Oliver, Marc Cucurull, Ignacio Blanco, Claudia Valverde, César Serrano, Eduard Serra, Cleofé Romagosa

Open source

DOI: 10.1016/j.prp.2026.156700
Published: 2026-12
Container: Pathology - Research and Practice
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.prp.2026.156700,
  title = {Inflammatory rhabdomyoblastic tumor: Clinicopathologic and genomic features, association with neurofibromatosis type 1, and progression to rhabdomyosarcoma},
  author = {Tulio M. Silva and Marta Sesé and Miriam Magallón-Lorenz and Gustavo Tapia and Juan C. Tardío and Javier Hernandez-Losa and Bernat Gel and Nikaoly Ciriaco and Alejandro Alegría and Rosario Granados and Irma Ramos-Oliver and Marc Cucurull and Ignacio Blanco and Claudia Valverde and César Serrano and Eduard Serra and Cleofé Romagosa},
  year = {2026},
  journal = {Pathology - Research and Practice},
  doi = {10.1016/j.prp.2026.156700},
  url = {https://doi.org/10.1016/j.prp.2026.156700}
}

RIS

TY  - JOUR
TI  - Inflammatory rhabdomyoblastic tumor: Clinicopathologic and genomic features, association with neurofibromatosis type 1, and progression to rhabdomyosarcoma
AU  - Tulio M. Silva
AU  - Marta Sesé
AU  - Miriam Magallón-Lorenz
AU  - Gustavo Tapia
AU  - Juan C. Tardío
AU  - Javier Hernandez-Losa
AU  - Bernat Gel
AU  - Nikaoly Ciriaco
AU  - Alejandro Alegría
AU  - Rosario Granados
AU  - Irma Ramos-Oliver
AU  - Marc Cucurull
AU  - Ignacio Blanco
AU  - Claudia Valverde
AU  - César Serrano
AU  - Eduard Serra
AU  - Cleofé Romagosa
PY  - 2026
JO  - Pathology - Research and Practice
DO  - 10.1016/j.prp.2026.156700
UR  - https://doi.org/10.1016/j.prp.2026.156700
ER  -

APA

Silva, T. M., Sesé, M., Magallón-Lorenz, M., Tapia, G., Tardío, J. C., Hernandez-Losa, J., Gel, B., Ciriaco, N., Alegría, A., Granados, R., Ramos-Oliver, I., Cucurull, M., Blanco, I., Valverde, C., Serrano, C., Serra, E., & Romagosa, C. (2026). Inflammatory rhabdomyoblastic tumor: Clinicopathologic and genomic features, association with neurofibromatosis type 1, and progression to rhabdomyosarcoma. Pathology - Research and Practice. https://doi.org/10.1016/j.prp.2026.156700

Source records

crossref · retrieved 2026-11-08T15:51:08.980Z